Prospective Observational Cohort Study to Describe the Use of Panitumumab in Combination with Chemotherapy in Real-World Clinical Practice for Patients with Wild-Type RAS mCRC.

Affiliation

Department of Internal Medicine, Stauferklinikum Schwäbisch Gmünd, Mutlangen, Germany. [Email]

Abstract

This study aimed to better understand panitumumab use in real-life clinical practice in first- and second-line treatment of metastatic colorectal cancer in five European countries.

Keywords

Metastatic colorectal cancer,Observational study,Panitumumab,RAS wild-type,Real-world data,Tumor location,